Company news

Ligand Pharmaceuticals Incorporated news in 2026

Ligand Pharmaceuticals Incorporated's news releases, calls and decks from 2026, newest first.

View company

Ligand Reports Third Quarter 2026 Financial Results

October 29, 2026

Ligand to Participate in November Investor Conferences

October 27, 2026

Ligand to Host Investor Day on December 8, 2026

October 22, 2026

Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026

October 15, 2026

Ligand Acquires Royalty and Milestone Interest in Santen’s Ryjunea® from Sydnexis for $23 Million

September 22, 2026

Ligand to Report Second Quarter 2026 Financial Results on August 6, 2026

July 23, 2026

Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets

July 13, 2026

Ligand Announces Pricing of Upsized $625 Million Convertible Senior Notes Offering

June 23, 2026

Ligand Announces Proposed Offering of $550 Million of Convertible Senior Notes Due 2031

June 22, 2026

Ligand Announces 2026 Investor Day in New York City

June 10, 2026

Ligand to Participate in June Investor Conferences

May 27, 2026

Ligand Reports First Quarter 2026 Financial Results

May 7, 2026

XOMA Royalty: Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator

April 26, 2026

Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator

April 27, 2026

Ligand to Report First Quarter 2026 Financial Results on May 7, 2026

April 22, 2026

Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan) in FSGS

April 13, 2026

Ligand Advances Strategic Growth with Expanded and Strengthened Business Development Team

March 25, 2026

Ligand Reports Fourth Quarter and Full Year 2025 Financial Results

February 25, 2026

Ligand to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

February 12, 2026

Ligand to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

February 3, 2026

Calls in 2026

Decks in 2026